Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life

NCT07257861 · clinicaltrials.gov ↗

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

OTHER: Questionnaires

Sponsor

Centre Hospitalier Régional d'Orléans

Collaborators

[object Object]
[object Object]